MedPath

Observational study to translate and validate EORTC QLQ-TC26 questionnaire into Hindi and Marathi.

Not Applicable
Conditions
Health Condition 1: C629- Malignant neoplasm of testis, unspecified whether descended or undescended
Registration Number
CTRI/2020/09/027927
Lead Sponsor
Tata Memorial Centre
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients diagnosed with testicular cancer and are being treated or have received treatment in uro-oncology DMG at Tata Memorial Centre, Mumbai.

2.Patient should be literate and fluent in either Hindi or Marathi.

3.Age >= 18 years.

4.Patients with ECOG PS 0-2

Exclusion Criteria

1.Patient on treatment who has developed a serious adverse event and is not medically fit to answer the self-administered questionnaire and/or participate in the interview.

2.Patient with psychiatric illness or any condition which interferes with their comprehension or the ability to answer the EORTC TC-26 questionnaire.

3.Patient who is not able to communicate due to any reason with the translation coordinator (TC) during pilot testing interviews.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Validation of the Hindi and Marathi translations of the TC-26 questionnaires by patients diagnosed with testicular cancer.Timepoint: 1 year
Secondary Outcome Measures
NameTimeMethod
ilTimepoint: Nil
© Copyright 2025. All Rights Reserved by MedPath